ReproCELL Incorporated (FRA:6RC)

Market Cap	88.71M +36.1%
Revenue (ttm)	13.68M -7.3%
Net Income	-1.76M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,050
Average Volume	n/a
Open	0.7350
Previous Close	0.7650
Day's Range	0.7350 - 0.7350
52-Week Range	0.5200 - 1.1000
Beta	n/a
RSI	56.85
Earnings Date	Feb 12, 2026

About ReproCELL

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, StemEdit gene edited iPSCs, mesenchymal stem cells (MSCs), and new immortalized cell lines and related reagents; and iPSC-...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2003
• Employees: 99
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 6RC

Financial Performance

Financial numbers in JPY